IL6 and Insulin resistance: Moreover, the selective blockade of IL-6 trans-signaling (and not IL-6R) prevents AT macrophage accumulation in HFD-induced obese mouse models without exacerbating insulin resistance (380), suggesting that targeting IL-6 trans signaling could also be a more favorable option for inflammatory diseases.